BioSpace News Archive

Toronto, Ontario--(Newsfile Corp. - May 15, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company”), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as...

iCAD, Inc. today reported its financial and operating results for the three months ended March 31, 2024.

Reviva Pharmaceuticals Holdings, Inc. today announced an enrollment update to the ongoing 1-year open-label extension (OLE) study evaluating the long-term safety and tolerability of brilaroxazine in patients with schizophrenia.

Ractigen Therapeutics today announces that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for the initiation of Phase 1 clinical trials in China for RAG-17, targeting Amyotrophic Lateral Sclerosis (ALS).

Entera Bio Ltd. today announced the appointment of Rachel B Wagman, MD, FACE, FACP, as Key Clinical Advisor and Member of its Scientific Advisory Board.

Eli Lilly and Company announced that Alonzo Weems, executive vice president of enterprise risk management and chief ethics and compliance officer, and a member of Lilly’s Executive Committee, will retire after 27 years of service with the company, effective Dec. 31, 2024.

Intensity Therapeutics, Inc. announces the appointment of Thomas Dubin, J.D., MPH, to the Intensity Board of Directors, effective May 14, 2024.

RaeSedo, Inc. today announced that it will present its pioneering approach to asthma treatment as a showcase company at the 2024 American Thoracic Society (ATS) Respiratory Innovation Summit (RIS).

Gate Neurosciences today announced upcoming activities at the 2024 annual meeting of the American Society of Clinical Psychopharmacology (ASCP), being held in Miami Beach, FL, from May 28-31, 2024.

TriSalus Life Sciences Inc., announced its financial results for the first quarter ended March 31, 2024, and provided a business update.